Tenax Therapeutics, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.38 | — | — | Miss |
| Q22026 FY2026 | $-0.38 | $-0.35 | +7.9% | Beat |
| Q12026 FY2026 | $-0.40 | $-0.35 | +12.5% | Beat |
| Q42025 FY2025 | $-1.26 | $-0.38 | +69.8% | Beat |
Back to TENX overview · TENX holders · TENX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.